Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia

Clinical trial NCT01556763 · COMPLETED

Trial details

NCT number: NCT01556763
Sponsor: FORUM Pharmaceuticals Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Central Nervous System Diseases

Start date: 2008-04-01
Primary completion: 2008-08-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.